TruTechnologies Receives Growth Investment from LLR Partners
Deal News | May 28, 2025 | LLR Partners Inc
LLR Partners has made a strategic growth investment in TruTechnologies, a company revolutionizing real-time clinical trial oversight. With LLR's support, TruTechnologies aims to enhance operational efficiency across research sites by offering cutting-edge solutions such as TruLab, TruDose, and TruScreen. This investment will assist TruTechnologies in expanding its capabilities to provide transparency and improved oversight for pharmaceutical companies and clinical research organizations. BofA Securities advised TruTechnologies, while Wachtell, Lipton, Rosen & Katz and DLA Piper offered legal counsel. LLR's investment underscores its role in supporting innovation in life sciences and healthcare sectors.
Sectors
- Life Sciences
- Healthcare Technology
- Private Equity
Geography
- United States – The investment involves LLR Partners, BofA Securities and legal advisors Wachtell, Lipton, Rosen & Katz and DLA Piper, all of which are based in or have significant operations within the United States.
Industry
- Life Sciences – The article primarily involves companies operating within the life sciences sector, focusing on improving clinical trials and drug development processes.
- Healthcare Technology – TruTechnologies provides advanced software solutions for clinical trial oversight, placing it squarely in the healthcare technology industry.
- Private Equity – LLR Partners, a private equity firm, is facilitating investment and growth within the clinical research sphere.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| LLR Partners Inc. | Investor | Company | A private equity firm investing in growth-focused companies in healthcare, technology, and other sectors. |
| TruTechnologies | Target | Company | A leading provider of real-time clinical trial oversight solutions, facilitating improved management of biological samples and study workflows. |
| BofA Securities, Inc. | Financial Advisor | Company | Served as the exclusive financial advisor to TruTechnologies in the transaction. |
| Wachtell, Lipton, Rosen & Katz | Legal Advisor to TruTechnologies | Company | Provided legal guidance to TruTechnologies during the investment transaction. |
| DLA Piper | Legal Advisor to LLR Partners | Company | Provided legal counsel to LLR Partners in their investment in TruTechnologies. |
| Scott Ogle | Co-Founder and CEO of TruTechnologies | Person | Leads TruTechnologies and is focused on addressing clinical research inefficiencies. |
| Rick Graham, PhD | Co-Founder and Chairman of TruTechnologies | Person | Helps lead TruTechnologies and emphasizes transparency in clinical trials. |
| Zack Sigal | Partner at LLR Partners | Person | A partner at the private equity firm involved in the investment. |
| William Sadock | Vice President at LLR Partners | Person | A representative of LLR Partners involved in strategizing the investment. |